| Therapeutic Advantage Llc | |
|
30903 W 10 Mile Rd Ste B, Farmington Hills, MI 48336 | |
| (248) 893-6192 | |
| Not Available |
| Full Name | Therapeutic Advantage Llc |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 30903 W 10 Mile Rd Ste B, Farmington Hills, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184038341 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 5201008046 (Michigan) | Primary |
| Provider Name | Jessica Ravineala |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1447531769 PECOS PAC ID: 9638395700 Enrollment ID: I20140725000866 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Andrea M House |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1215113246 PECOS PAC ID: 2961720107 Enrollment ID: I20150418000001 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Stefanie Mitchell |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1013423508 PECOS PAC ID: 4688932619 Enrollment ID: I20171221001521 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Jaimie Marie Durden |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1376069450 PECOS PAC ID: 2466792270 Enrollment ID: I20190313003006 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Julianne Claire Martin |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1982261731 PECOS PAC ID: 7012244379 Enrollment ID: I20190808002445 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Megan Marie Metcalf |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1336677673 PECOS PAC ID: 2163849696 Enrollment ID: I20200831000131 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Christina Yaldo |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1407442072 PECOS PAC ID: 6507279155 Enrollment ID: I20201229000877 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Taylor Naumann |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1700490653 PECOS PAC ID: 9032524301 Enrollment ID: I20210218001679 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Janel Davis-heitzmann |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1164735841 PECOS PAC ID: 5496158016 Enrollment ID: I20210720002997 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Tori Bakewell |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1134747181 PECOS PAC ID: 3173927589 Enrollment ID: I20210806002652 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Muhiba Mehmedovic |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1487173068 PECOS PAC ID: 4082019278 Enrollment ID: I20210826001314 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Bianca Aakesson |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1881267318 PECOS PAC ID: 4183021686 Enrollment ID: I20210927001625 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Anya Rowe |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1760144257 PECOS PAC ID: 6901204445 Enrollment ID: I20211013001834 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Rachel Marie Wills |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1093218190 PECOS PAC ID: 9739569930 Enrollment ID: I20220706001446 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Jennifer L Rhein |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1194008938 PECOS PAC ID: 0840670782 Enrollment ID: I20220708002394 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Amma Perozo Morles |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1396455192 PECOS PAC ID: 7618346016 Enrollment ID: I20221207000181 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Elizabeth Parr |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1174240188 PECOS PAC ID: 6507236767 Enrollment ID: I20230104000636 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Theresa Marie Saporito |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1043717689 PECOS PAC ID: 5597138834 Enrollment ID: I20230307001385 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Haley Samantha Seidman |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1003468307 PECOS PAC ID: 8527427343 Enrollment ID: I20230711001945 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Provider Name | Olivia Oldham |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1588445928 PECOS PAC ID: 2961850227 Enrollment ID: I20231127002140 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Therapeutic Advantage Llc 30903 W 10 Mile Rd Ste B, Farmington Hills, MI 48336-2615 Ph: () - | Therapeutic Advantage Llc 30903 W 10 Mile Rd Ste B, Farmington Hills, MI 48336 Ph: (248) 893-6192 |
News Archive
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
If people are educated on recycled water, they may come to agree it's perfectly safe and tastes as good - or better - than their drinking water.
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.
› Verified 3 days ago
Maureen Ann Kuznicki, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 248-471-8759 Fax: 248-471-8607 | |
Karen Watson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 248-471-8604 | |
Mr. Daniel Joseph Parsell, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 34505 W 12 Mile Rd Ste 100, Farmington Hills, MI 48331 Phone: 855-559-7178 | |
Stefanie Mitchell, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 30903 W 10 Mile Rd Ste B, Farmington Hills, MI 48336 Phone: 248-893-6192 | |
Kristin Voigt, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 947-521-8753 | |
Erin Torrence, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 30903 W 10 Mile Rd Ste B, Farmington Hills, MI 48336 Phone: 248-893-6192 Fax: 248-457-5490 | |
Patricia Lynn Jarvis, OTL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 34505 W 12 Mile Rd Ste 100, Farmington Hills, MI 48331 Phone: 855-559-7178 |